Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03769519 · ClinicalTrials.gov registry record · NA

AdheRence to Inhaled Corticosteroids in Asthma

A NA study of Asthma and Medication Adherence, sponsored by Duke University.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT03769519 is a NA study of Asthma and Medication Adherence that has completed, run by Duke University. The registered enrollment target is 29 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03769519, a NA study of Asthma and Medication Adherence, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.

Interventions

  • BEHAVIORAL ARICA

Study Locations (1)

North Carolina

  • Duke Un. - Durham

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2020-02-27
Est. Completion 2020-08-19
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03769519

The ClinicalTrials.gov registry entry for NCT03769519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which ARICA is the first listed.

NCT03769519 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03769519 about?

NCT03769519 is a clinical study titled "AdheRence to Inhaled Corticosteroids in Asthma". It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adhe...

What is the current status of trial NCT03769519?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2020-02-27. Estimated completion is 2020-08-19.

What conditions does trial NCT03769519 study?

This clinical trial studies the following conditions: Asthma, Medication Adherence.

What interventions are being tested in trial NCT03769519?

The interventions under investigation include: ARICA (BEHAVIORAL).

Who is sponsoring clinical trial NCT03769519?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03769519 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.